中文
| Catalogue |
| Recommend Products |
Company News
- Tumor Neoantigen-Based Immunotherapy: Ushering in a New Era of Precision Cancer Treatment 3/22/2026
- Thrombin Antibodies & Aptamer Technology: Revolutionizing Anticoagulation Treatment Strate... 3/21/2026
- The Key Role and Application Advances of IFN-γ Detection in CAR-T Cell Therapy Development... 3/20/2026
- Mouse ELISA Kits: Accurate Insulin Quantification to Advance Metabolic Research 3/19/2026
- PSMA-Targeted Nanobodies: Revolutionizing Diagnosis and Treatment Strategies for Prostate ... 3/18/2026
- Prolactin/PRL Antibodies: Unraveling Sex-Specific Regulatory Mechanisms in Glioma Progress... 3/17/2026
- Protein Propionylation: Advances and Applications in Metabolic Regulation and Disease Rese... 3/16/2026
- PCSK9 Antibodies: Pioneering Technological Revolutions and Clinical Breakthroughs in Lipid... 3/15/2026
- PSD-95 Antibodies: Ushering in a New Era of Neuroprotection for Ischemic Stroke Treatment 3/14/2026
- PSEN1 Antibodies: Unveiling the Pathogenic Mechanisms of Alzheimer's Disease and Novel The... 3/13/2026
- Mouse T Cell Activation: A Systematic Guide to Developmental Differentiation and Immune Fu... 3/12/2026
- Mouse T Cell Activation Kits: Enabling Efficient Immune Activation Through the CD3/CD28 Du... 3/11/2026
- Cas9 Antibodies: Ensuring Precision and Reproducibility in Gene Editing Research 3/10/2026
- Recombinant Rabbit Monoclonal Antibodies: Revolutionizing the Precision and Reliability of... 3/9/2026
- Neural Research Antibodies: The Key to Unraveling the Mysteries of the Brain 3/8/2026
- The Key Role of CK-Pan Antibody in Cell Biology Research 3/7/2026
- Site-Selective Acetylation: Unlocking New Functional Horizons for Antibody Drugs 3/6/2026
- Lactylation Antibodies: Deciphering Novel Molecular Mechanisms of Metabolic Reprogramming ... 3/5/2026
- Monoclonal Antibodies: Achieving Precise Targeted Therapy Through Structural Optimization ... 3/3/2026
- CD14-Positive Sorting: Advancing the Precise Development of Monocyte-Related Immunology Re... 3/2/2026